Chasing the Biopharma Market: From New Customer Bases and Vaccines to Biosimilars and Antibodies
Vaccines are absolutely crucial for maintaining global health, but are a challenge to develop and...
The biopharmaceutical industry has a reputation for being averse to change. This is likely because traditional approaches to drug development have withstood the test of time, delivering safe and effective drugs for decades.
However, new market dynamics, such as growing competition from biosimilars and niche drugs targeting smaller patient populations are reshaping how drugs are produced and sold. The saying 'If it isn’t broke, don’t fix it' no longer suffices in a market focused more on efficiency and flexibility in manufacturing.
Instead, these qualities have become the foundation of managing demand uncertainty and appropriately preparing for a wide range of possible launch outcomes
Vaccines are absolutely crucial for maintaining global health, but are a challenge to develop and...
Akeso Pharmaceuticals, a biotech company that focuses in the growth and commercialisation of innovative biologics,...
GE Healthcare (GEHC) and the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin,...
When you partner with GE Healthcare’s Life Sciences you get access to a wide selection...